A hot (if cautious) topic at the big gene therapy meeting: what Vinay Prasad's appointment might mean for approvals in rare ...

Health secretary RFK Jr. earlier this week said it's Matthew Buzzelli, listed on the CDC's website as chief of staff. But the ...

At the American Society of Cell and Gene Therapy conference, there were questions and qualms on how Vinay Prasad may change ...

The FDA has approved the first blood test for diagnosing Alzheimer’s disease, which could speed the path to treatment for ...

Lars Fruergaard Jørgensen is stepping down as Novo Nordisk CEO, with the company citing its stock's recent struggles.

Ken Cohen, a physician and Optum’s executive director of translational research, said Thursday at a conference organized by ...

Kevin Hall, ultra-processed food expert, says he took retirement after the HHS censored his work and that, despite requests, ...

Leading oncologists said AI will one day be as integrated into cancer care as it is in smartphones and self-driving cars. #STATBreakthrough ...

From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry ...

House Democrats are backing the Justice Department case that alleges UnitedHealth Group committed widespread Medicare ...

Morning! Today we start with some breaking newss: Novo Nordisk’s CEO is stepping down. We also discuss a new, tailored CRISPR treatment for an infant with a deadly disease, how Amgen owes Regeneron ...

Novo Nordisk's CEO, who led its boom driven by obesity and diabetes medications only to see that success stall, is stepping ...